Scinovex
articleTop 1% cited

PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer

Gynecologic Oncology · 2016 · Vol. 141(2) · pp. 293–302
John R. WebbKaty MilneDavid R. KroegerBrad H. Nelson
Cancer Immunotherapy and BiomarkersImmune cells in cancerImmune Cell Function and InteractionCancer researchFOXP3Tissue microarrayOvarian cancerMedicineCD8Tumor-infiltrating lymphocytesGranzyme BImmune systemIL-2 receptor

MeSH terms

Carcinoma, Ovarian EpithelialFemaleHumansImmunohistochemistryMacrophagesNeoplasms, Glandular and EpithelialOvarian NeoplasmsPrognosisLymphocytes, Tumor-InfiltratingCystadenocarcinoma, SerousTissue Array AnalysisB7-H1 Antigen

Funding

  • U.S. Department of Defense
  • Health Canada
  • Canadian Institutes of Health Research
  • Canadian Cancer Society Research Institute
  • BC Cancer Agency
Citations
336
FWCI
18.75
field-weighted impact
References
40
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer · Scinovex